Fleeing India: What Will Make Clinical Trials Flood Back?

India's attractiveness as a hub for clinical trials, fueled by the lax regulatory system, is the very same reason why the clinical trial industry is now losing its luster

Untapped Opportunities: Brazil's Most Promising Regions for Pharma Manufacturing

Revealing Brazil's best kept manufacturing secrets

Ousted! How Sanctions against Russia Are Expected to Affect Pharma Investments

Will the attractiveness of the vast Russian market begin to falter in the near future?

Insight

First Name*

E-mail Address*

Company*

Country*

Last Name*

Title*

City*

How did you hear about STEM-Pharma?*